Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Login

|

2023
March 24
Webinar
LESI Life Sciences Committee "The current landscape in ATMP – IP, partnering, funding and more!"
LES International
Life Sciences Committee

Website: https://lesi-org.zoom.us/meeting/register/tZwpf-2hqTMuHt17sAkCQAYB-o8uWoSBtOXl

This webinar intends to discuss the current market in the advanced therapeutic medicinal product (ATMP) space, with a particular focus on the challenges specific to this sector, and how those impact on aspects such as due diligence, collaboration, funding and deals.

These topics will be explored using case studies from two ATMP companies at different growth stages, Quell Therapeutics and NK:IO. Additional insights on access to technology, and issues on manufacturing and supply chain being provided by our speaker from the Cell and Gene Therapy Catapult, which works to support companies in this sector.

SPEAKERS:

  • Matthew Garner - Head of IP, Cell and Gene Therapy Catapult
  • Jodie Albutt - VP of IP, Quell Therapeutics
  • Michael Hunt - CEO of NK:IO
  • Kerstin Papenfuss - Director, Pharma, Deep Science Ventures
  • Anna Gregson - Partner, Mathys & Squire LLP

Click here to find out more about the Speakers.

This event is free to participants.